NASDAQ: ELOX
Eloxx Pharmaceuticals Inc Earnings Dates, Reports, Calls

Eloxx Pharmaceuticals earnings were N/A for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest ELOX earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$3.8M, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ELOX reported annual earnings of -$6.0M, with 90.7% growth.

ELOX earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

ELOX Return on Equity

Current Company
N/A
Current Industry
-142.3%
Current Market
13.5%

ELOX Return on Assets

Current Company
N/A
Current Industry
-13.6%

Be the first to know when ELOX announces earnings.

ELOX Return on Capital Employed

Current Company
0%
Current Industry
-9.5%

ELOX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ELOXN/AN/AN/AN/A
JSPR-$53.78M-$55.73MN/A-$2.68
CYCN-$5.28M-$5.28MN/A-$1.36
CMMB-$8.93M-$9.00MN/A-$1.44
MBRX-$30.27M-$32.20MN/A-$2.16

Eloxx Pharmaceuticals Earnings Reports & History FAQ

What were Eloxx Pharmaceuticals's earnings last quarter?

Eloxx Pharmaceuticals (NASDAQ: ELOX) reported Q1 2026 earnings per share (EPS) of -$0.86, up 82.59% year over year. Total ELOX earnings for the quarter were -$3.75 million. In the same quarter last year, Eloxx Pharmaceuticals's earnings per share (EPS) was -$4.94.

If you're new to stock investing, here's how to buy Eloxx Pharmaceuticals stock.

Is Eloxx Pharmaceuticals profitable or losing money?

As of the last Eloxx Pharmaceuticals earnings report, Eloxx Pharmaceuticals is currently losing money. Eloxx Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2026 was N/A, a N/A decrease year over year.

What was ELOX's earnings growth in the past year?

As of Eloxx Pharmaceuticals's earnings date in Q2 2026, Eloxx Pharmaceuticals's earnings has grown year over year. ELOX earnings in the past year totalled N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.